Unlock instant, AI-driven research and patent intelligence for your innovation.

Tankyrase inhibitor

A technology of compounds and solvates, applied in the field of tankyrase inhibitors

Active Publication Date: 2017-10-03
BEIJING SIHUAN PHARMA
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, no small-molecule inhibitors targeting tankyrase have entered clinical research, so there is a huge demand for the application of this target in the field of cancer therapy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tankyrase inhibitor
  • Tankyrase inhibitor
  • Tankyrase inhibitor

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0106] Step 1 Preparation of intermediate 1

[0107] Intermediate 1 was obtained by purchase or preparation.

[0108] Step 2 Preparation of Intermediate 2

[0109] Intermediate 1 and raw material 1 were dissolved in an appropriate solvent (such as a mixed solution of triethylamine and N,N-dimethylformamide), and the reaction was complete at room temperature. Water and an organic solvent (such as dichloromethane) were added to separate the layers. The organic phase is dried, concentrated, and purified (eg, silica gel column chromatography) to obtain intermediate 2.

[0110] Step 3 Preparation of Intermediate 3

[0111] Dissolve intermediate 2 in a suitable solvent (such as tetrahydrofuran), add raw material 2 at 0°C, react at room temperature (for example, 10-20 hours), complete the reaction, filter, add water and an organic solvent (such as dichloromethane), and separate the layers , the organic phase was dried, concentrated, and purified (eg, silica gel column chromatograp...

experiment example 1

[0160] Experimental example 1 In vitro enzymatic activity test of the compound of the present invention

[0161] Test product: the compound of the present invention, its chemical name and preparation method are shown in the preparation examples of the compound.

[0162] (1) Compound preparation

[0163] Preparation of compound 10mM stock solution: Weigh an appropriate amount of the test product (see the table below for the specific weighing amount), add an appropriate amount of DMSO to dissolve, mix well, and set aside.

[0164] 10 mM stock solution was taken respectively, and diluted with DMSO to a solution with a concentration of 1 mM, which was used as the mother solution. The above mother solution was diluted 10 times with DMSO to prepare a series of solutions with concentrations, and then diluted 10 times with water to prepare solutions containing 10% DMSO, the concentrations were: 100 μM, 10 μM, 1 μM, 0.1 μM.

[0165]

[0166] (2) Experimental method

[0167] 1. Pre...

experiment example 2

[0193] Experimental example 2 The effect of the compound of the present invention on the protein of AXIN2 in SW480 cells

[0194] Test product: the compound of the present invention, its chemical name and preparation method are shown in the preparation examples of the compound.

[0195] (1) Preparation of the test product

[0196] Preparation of compound 10mM stock solution: Weigh an appropriate amount of compound (see the table below for the specific weighing amount), add appropriate amount of DMSO to dissolve, mix well, and set aside.

[0197] Take 10mM stock solutions respectively, and dilute the above mother solutions step by step with DMSO to make mother solutions with concentrations of 1mM and 0.2mM (×1000), then dilute them 1000 times with culture medium, and then add them to the corresponding wells of the 6-well plate. The final concentration of the obtained compound solution was: 1 μM, 0.2 μM.

[0198]

[0199] (2) Experimental method

[0200] 1. Cell culture:...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicines and particularly relates to a tankyrase inhibitor represented by a general formula (I) shown in the description and pharmaceutically acceptable salts, esters, solvates or stereoisomers thereof, wherein R1, R2, R3, m, n, Z, L, Q, A, X1, X2 and Y are as defined in the description. The invention further relates to a preparation method for the compounds, pharmaceutical preparations and pharmaceutical compositions containing the compounds and application of the compound and the pharmaceutically acceptable salts, esters, solvates or stereoisomers thereof in preparation of drugs for treating and / or preventing tankyrase mediated cancers and related diseases.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to tankyrase inhibitors, or pharmaceutically acceptable salts, esters, solvates and stereoisomers thereof, preparation methods of these compounds, pharmaceutical preparations and medicines containing these compounds Compositions, and the application of these compounds in the preparation of medicines for treating and / or preventing cancer, Alzheimer's disease, osteoporosis, skin diseases, cardiovascular diseases, and type II diabetes. Background technique [0002] As we all know, cancer has become one of the most serious diseases threatening human life and health, and more than nine million people around the world suffer from malignant tumors every year. Therefore, finding effective drugs and methods for the prevention and treatment of cancer has become an urgent task in today's society. Cancer is a disease characterized by loss of proper control of cell growth. Accordi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D401/12C07D239/90C07D487/04C07D471/04A61K31/517A61K31/4725A61K31/519A61K31/4545A61K31/496A61K31/53A61P35/00A61P25/28A61P19/10A61P17/00A61P9/00A61P3/10
CPCC07D239/90C07D401/12C07D471/04C07D487/04
Inventor 吴永谦亓蕖李琳
Owner BEIJING SIHUAN PHARMA